The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading
Top Cited Papers
Open Access
- 11 July 2017
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 40 (8), 994-999
- https://doi.org/10.2337/dc17-0636
Abstract
HbA1c is a valuable metric for comparing treatment groups in a randomized trial, for assessing glycemic trends in a population over time, or for cross-sectional comparisons of glycemic control in different populations. However, what is not widely appreciated is that HbA1c may not be a good indicator of an individual patient’s glycemic control because of the wide range of mean glucose concentrations and glucose profiles that can be associated with a given HbA1c level. To illustrate this point, we plotted mean glucose measured with continuous glucose monitoring (CGM) versus central laboratory–measured HbA1c in 387 participants in three randomized trials, showing that not infrequently HbA1c may underestimate or overestimate mean glucose, sometimes substantially. Thus, if HbA1c is to be used to assess glycemic control, it is imperative to know the patient’s actual mean glucose to understand how well HbA1c is an indicator of the patient’s glycemic control. With knowledge of the mean glucose, an estimated HbA1c (eA1C) can be calculated with the formula provided in this article to compare with the measured HbA1c. Estimating glycemic control from HbA1c alone is in essence applying a population average to an individual, which can be misleading. Thus, a patient’s CGM glucose profile has considerable value for optimizing his or her diabetes management. In this era of personalized, precision medicine, there are few better examples with respect to the fallacy of applying a population average to a specific patient rather than using specific information about the patient to determine the optimal approach to treatment.Keywords
Funding Information
- Leona M. and Harry B. Helmsley Charitable Trust
- The National Institute of Diabetes and Digestive and Kidney Diseases (DK108611)
- Leona M. and Harry B. Helmsley Charitable Trust
- Leona M. and Harry B. Helmsley Charitable Trust
This publication has 26 references indexed in Scilit:
- Estimation of the Glycation Gap in Diabetic Patients With Stable Glycemic ControlDiabetes Care, 2012
- Evidence for Consistency of the Glycation Gap in DiabetesDiabetes Care, 2011
- Persistence of Individual Variations in Glycated HemoglobinDiabetes Care, 2011
- Hemoglobin A1c and Mean Glucose in Patients With Type 1 DiabetesDiabetes Care, 2011
- HbA1c for the Diagnosis of Diabetes and Prediabetes: Is It Time for a Mid-Course Correction?Journal of Clinical Endocrinology & Metabolism, 2010
- Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1cBlood, 2008
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- Relationship of A1C to Glucose Concentrations in Children With Type 1 DiabetesDiabetes Care, 2008
- Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic ControlClinical Chemistry, 2007
- High and low hemoglobin glycation phenotypes in type 1 diabetes: A challenge for interpretation of glycemic controlJournal of Diabetes and its Complications, 2002